Finance

Lists
Why is AUPH up ၂.၆၅%?
Dive Deeper
AUPH:NASDAQ
Aurinia Pharmaceuticals Inc
၁၆.၆၅ US$
+၂.၆၅%
(+၀.၄၃) 1D
၁၆.၇၁ US$
+၀.၃၇% (+၀.၀၆၂)
After hours
Closed: အောက် ၉, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AUPH...
Open
၁၆.၁၆ US$
High
၁၆.၉၇ US$
Low
၁၆.၁၂ US$
Mkt. cap
၂၂၁.၅၃ ဋေ
Avg. vol.
၈.၀၆ သိန်း
Volume
၈.၄၉ သိန်း
P/E ratio
၇.၂၇
52-wk high
၁၉.၂၅ US$
52-wk low
၁၀.၉၂ US$
EPS
၂.၂၉ US$
Beta
၁.၆၀
Shares outstanding
၁၃.၃၁ ကုဋေ
No. of employees
၁၂၈
Open
၁၆.၁၆ US$
High
၁၆.၉၇ US$
Low
၁၆.၁၂ US$
Mkt. cap
၂၂၁.၅၃ ဋေ
Avg. vol.
၈.၀၆ သိန်း
Volume
၈.၄၉ သိန်း
P/E ratio
၇.၂၇
52-wk high
၁၉.၂၅ US$
52-wk low
၁၀.၉၂ US$
EPS
၂.၂၉ US$
Beta
၁.၆၀
Shares outstanding
၁၃.၃၁ ကုဋေ
No. of employees
၁၂၈
News stories
From web sources and news partners
The Business Journals
The Business Journals
·
ပြီးခဲ့သည့် ၃ ရက်
Aurinia Pharmaceuticals plots early exit from Montgomery County lease following leadership overhaul
About Aurinia Pharmaceuticals Inc
CEO-
Employees၁၂၈
Founded၂၀၁၂
Headquartersအက်ဒ်မန်တန်, အယ်လဗားတားပြည်နယ်, ကနေဒါ
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to AUPH in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AUPH in the last 3 months.
Highest
Current ၁၆.၆၅ US$
၂၁.၀၀ US$ (+၂၆.၁၃%)
Average
၁၈.၀၀ US$ (+၈.၁၁%)
Lowest
၁၆.၀၀ US$ (-၃.၉၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Martin PhD
Bloom Burton
Buy
Upgraded
၂၁.၀၀ US$
+၂၆.၁%
08/20/2026
Stacy Ku
TD Cowen
Buy
Maintained
၁၇.၀၀ US$
+၂.၁%
08/19/2026
Douglas Miehm
RBC Capital
Hold
Maintained
၁၆.၀၀ US$
-၃.၉%
08/07/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
၁၇.၀၀ US$
+၂.၁%
02/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၇.၃၅ ကုဋေ
၇.၇၁ ကုဋေ
၇.၇၇ ကုဋေ
၈.၃၂ ကုဋေ
Cost of goods sold
၈.၅၀ သန်း
၄.၀၅ ကုဋေ
၁.၄၀ ကုဋေ
၁.၈၃ ကုဋေ
Cost of revenue
၈.၅၀ သန်း
၄.၀၅ ကုဋေ
၁.၄၀ ကုဋေ
၁.၈၃ ကုဋေ
Research and development expenses
၈.၁၁ သန်း
-၂.၀၉ ကုဋေ
-
၁.၃၁ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂.၆၂ ကုဋေ
၂.၉၃ ကုဋေ
၂.၂၀ ကုဋေ
၂.၃၅ ကုဋေ
Operating expense
၃.၅၂ ကုဋေ
-၆.၃၇ သန်း
၂.၂၃ ကုဋေ
၁.၈၆ ကုဋေ
Total operating expenses
၄.၃၇ ကုဋေ
၃.၄၂ ကုဋေ
၃.၆၃ ကုဋေ
၃.၆၉ ကုဋေ
Operating income
၂.၉၇ ကုဋေ
၄.၂၉ ကုဋေ
၄.၁၄ ကုဋေ
၄.၆၃ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
၃.၂၀ ကုဋေ
၃.၅၇ ကုဋေ
၄.၃၉ ကုဋေ
၄.၈၈ ကုဋေ
EBT excluding unusual items
၃.၂၀ ကုဋေ
၃.၅၇ ကုဋေ
၄.၃၉ ကုဋေ
၄.၈၈ ကုဋေ
Income tax expense
၄.၁၁ သိန်း
-၁၇.၅၁ ကုဋေ
၉.၅၇ သန်း
၁.၁၄ ကုဋေ
Effective tax rate
၁.၂၉%
-၄၉၀.၆၂%
၂၁.၇၉%
၂၃.၃၁%
Other operating expenses
၉.၂၉ သိန်း
-၁.၄၈ ကုဋေ
၂.၇၉ သိန်း
-၆.၂၃ သန်း
Net income
၃.၁၆ ကုဋေ
၂၁.၀၈ ကုဋေ
၃.၄၄ ကုဋေ
၃.၇၄ ကုဋေ
Net profit margin
၄၂.၉၅%
၂၇၃.၃၅%
၄၄.၂၁%
၄၄.၉၆%
Earnings per share
၀.၂၃
၁.၅၃
၀.၂၅
၀.၂၈
Interest and investment income
၃.၃၂ သန်း
၃.၅၀ သန်း
၃.၅၂ သန်း
၃.၃၉ သန်း
Interest expense
-၁.၁၀ သန်း
-၁.၀၅ သန်း
-၁.၀၁ သန်း
-၉.၄၈ သိန်း
Net interest expenses
၂.၂၂ သန်း
၂.၄၅ သန်း
၂.၅၀ သန်း
၂.၄၄ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၃.၄၆ ကုဋေ
၄.၇၈ ကုဋေ
၄.၆၂ ကုဋေ
၅.၁၂ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ